Scientific Datafrom Clinical Trials: Investigators' Responsibilities and Rights

Abstract

Get full access to this article

View all access options for this article.

References

Rutherford

, Johnston

. Potential problems with industry-supported research. J Vasc Surg 2000;31:1066–76.

Weatherall

. Academia and industry: increasingly uneasy bedfellows. Lancet 2000;355:1574.

Angell

. Is academic medicine for sale? N Engl J Med 2000;342:1516–8.

Bodenheimer

. Uneasy alliance—clinical investigators and the pharmaceutical industry. N Engl J Med 2000;342:1539–44.

Goldstein

, Brott

, Kothari

, Smith

. Clinical stroke trials: guarding against bias. Stroke 1999;30:1165–7.

Hailey

. Scientific harassment by pharmaceutical companies: time to stop. CMAJ 2000;162:212–3.

Rennie

. Fair conduct and fair reporting of clinical trials. JAMA 1999;282:1766–8.

Kahn

, Cheng

, Mayer

, Murray

, Lagakos

. Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 10⁶/L CD4 cell counts: a randomized controlled trial. JAMA 2000;284:2193–202.

Blumenthal

, Campbell

, Anderson

, Causino

, Louis

. Withholding research results in academic life science; evidence from a national survey of faculty. JAMA 1997;277:1224–8.

10.

Rutherford

, Johnston

. Protecting the rights of investigators in industry supported clinical research. J Vasc Surg. In press 2002.

11.

Davidoff

, DeAngelis

, Drazen

, Hoey

, Hojgaard , Lhorton

, . Sponsorship, authorship, and accountability. N Engl J Med 2001;345:825.